4-Bromo-2-iodo-1-(trifluoromethyl)benzene: Properties & Uses
4-Bromo-2-iodo-1-(trifluoromethyl)benzene: Properties & Uses
4-Bromo-2-iodo-1-(trifluoromethyl)benzene is a polyhalogenated, electron-deficient aromatic building block bearing two orthogonally reactive halogen substituents and a strongly electron-withdrawing trifluoromethyl group, making it a versatile reagent for selective cross-coupling and other transition-metal-catalysed transformations in medicinal and materials chemistry research.
- IUPAC Name
- 4-Bromo-2-iodo-1-(trifluoromethyl)benzene
- Molecular Formula
- C7H3BrF3I
- Molecular Weight
- 350.90 g/mol
- Key Functional Groups
- Aryl iodide, aryl bromide, trifluoromethyl (CF3)
- Primary Application
- Selective cross-coupling reactions (e.g., Suzuki, Sonogashira, Buchwald-Hartwig)
- SKU
- B180721
Chemical Identity and Physical Properties
4-Bromo-2-iodo-1-(trifluoromethyl)benzene (SKU: B180721) is a trisubstituted benzene derivative carrying a bromine atom at the 4-position, an iodine atom at the 2-position, and a trifluoromethyl (CF3) group at the 1-position. Its molecular formula is C7H3BrF3I, corresponding to a molecular weight of approximately 350.90 g/mol.
The compound is typically encountered as a colourless to pale-yellow liquid or low-melting solid at ambient temperature. The trifluoromethyl group is a powerful electron-withdrawing substituent that significantly lowers the electron density of the aromatic ring, activating it towards nucleophilic aromatic substitution and modulating the reactivity of both halogen leaving groups. The simultaneous presence of two different halogens—iodine and bromine—on the ring is the defining feature that grants this compound its synthetic versatility.
Reactivity and Selectivity in Cross-Coupling Chemistry
The central utility of 4-Bromo-2-iodo-1-(trifluoromethyl)benzene in synthetic chemistry derives from the well-established difference in oxidative-addition kinetics between aryl iodides and aryl bromides toward palladium(0) and other transition-metal catalysts. Aryl iodides undergo oxidative addition significantly faster than aryl bromides under mild conditions, enabling chemoselective single-site functionalisation at the C–I bond while leaving the C–Br bond intact.
This orthogonal reactivity allows chemists to perform sequential cross-coupling sequences: the C–I bond can be engaged first in reactions such as Suzuki–Miyaura (boronic acid coupling), Sonogashira (terminal alkyne coupling), Negishi (organozinc coupling), or Buchwald–Hartwig (C–N bond formation) couplings under mild palladium catalysis. Subsequently, the remaining C–Br bond can be activated under more forcing conditions or with alternative catalyst systems to install a second, distinct fragment. This two-step diversification strategy makes the compound especially valuable for constructing complex, multiply-functionalised fluorinated arene scaffolds used in pharmaceutical and agrochemical lead optimisation.
The electron-withdrawing CF3 group further modulates reactivity by stabilising anionic intermediates and influencing the regioselectivity of nucleophilic additions, complementing the halogen-selectivity strategy.
Applications in Medicinal and Materials Chemistry
Fluorinated aromatic compounds occupy a prominent position in modern drug discovery. The incorporation of a CF3 group into a drug candidate typically improves metabolic stability, membrane permeability, and lipophilicity relative to the non-fluorinated parent compound, while also modulating pKa values of nearby functional groups. 4-Bromo-2-iodo-1-(trifluoromethyl)benzene serves as a late-stage building block for the synthesis of trifluoromethylated biaryl and heteroaryl scaffolds commonly found in kinase inhibitors, GPCR ligands, and other therapeutic agents.
In materials chemistry, fluorinated arenes are valued for their high chemical stability, unique dielectric properties, and ability to participate in fluorine-directed intermolecular interactions. The compound can serve as a monomer or intermediate in the preparation of fluorinated conjugated polymers and liquid-crystal materials, where the CF3 group influences mesophase behaviour and electronic properties.
The compound is also used as a diagnostic intermediate in radiolabelling workflows, particularly as a precursor for the introduction of fluorine-containing motifs relevant to PET tracer development, though specific radiolabelling protocols should be validated independently.
Handling, Storage, and Safety Considerations
As with all halogenated aromatic compounds, 4-Bromo-2-iodo-1-(trifluoromethyl)benzene should be handled with appropriate laboratory precautions. Personnel should use nitrile or neoprene gloves, safety glasses, and work in a well-ventilated fume hood to minimise inhalation or dermal exposure. Although the compound is not classified as acutely highly toxic, the general principles of chemical hygiene apply.
The compound should be stored in a tightly sealed container, protected from light and moisture, at cool temperatures (typically 2–8 °C or as specified on the product label) to prevent degradation or hydrolysis of the sensitive C–I bond over extended periods. Compatibility with common laboratory solvents such as dichloromethane, tetrahydrofuran, dimethylformamide, and toluene is generally good.
Researchers should consult the current Safety Data Sheet (SDS) provided by Aladdin Scientific for authoritative hazard classification, first-aid measures, disposal guidance, and regulatory information before use. Specific GHS classifications and H/P statements should be verified from the SDS, as these may vary by jurisdiction and regulatory update cycle.
Frequently asked questions
Why is the C–I bond more reactive than the C–Br bond in cross-coupling reactions?
The carbon–iodine bond is longer and weaker than the carbon–bromine bond, resulting in a lower activation barrier for oxidative addition into palladium(0) and other transition-metal catalysts. This kinetic preference allows chemists to selectively functionalise the C–I position of 4-Bromo-2-iodo-1-(trifluoromethyl)benzene under mild conditions while preserving the C–Br bond for subsequent transformations.
What solvents are recommended for reactions using this compound?
Common solvents for cross-coupling reactions involving aryl halides include tetrahydrofuran (THF), 1,4-dioxane, dimethylformamide (DMF), toluene, and acetonitrile, depending on the specific reaction type and catalyst system employed. The compound shows good solubility in these standard organic solvents. The optimal solvent should be determined empirically for each specific transformation.
How should 4-Bromo-2-iodo-1-(trifluoromethyl)benzene be stored to maintain its integrity?
The compound should be stored in a tightly sealed container, away from light and moisture, at cool temperatures (2–8 °C is generally recommended). Aryl iodides can be sensitive to prolonged exposure to light and ambient humidity, which may lead to slow decomposition. Always verify storage conditions on the current product label and SDS from Aladdin Scientific.
Can this compound be used as a precursor for introducing a CF3 group, or does the CF3 group remain intact throughout reactions?
In standard cross-coupling reactions (Suzuki, Sonogashira, Buchwald-Hartwig, etc.), the CF3 group on the aromatic ring remains chemically inert and is carried through intact into the product. The compound acts as a CF3-bearing arene scaffold rather than a CF3-transfer reagent. Selective modification occurs at the C–I and C–Br positions, not at the CF3 substituent.
References
- Negishi, E. (Ed.) Handbook of Organopalladium Chemistry for Organic Synthesis. Wiley-Interscience, 2002. General reference for cross-coupling selectivity of aryl halides.
- Kirsch, P. Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications. Wiley-VCH, 2004. Reference for CF3-containing arene properties and applications.
- Johansson Seechurn, C. C. C.; Kitching, M. O.; Colacot, T. J.; Snieckus, V. Palladium-Catalyzed Cross-Coupling: A Historical Contextual Perspective to the 2010 Nobel Prize. Angew. Chem. Int. Ed. 2012, 51, 5062–5085. doi:10.1002/anie.201107017
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)